Addex Therapeutics, a leading company pioneering allosteric modulation-based drug discovery and development, has announced top-line data from a Phase 2a clinical study of ADX71149 in anxious depression, conducted by Janssen Research & Development, LLC, on behalf of its af...
Tags: Depression, Clinical Study
Show per page
1 of 1 Page
Popular tags in SelectScience